The Gliotransmitter d-Serine Promotes Synapse Maturation and Axonal Stabilization In Vivo | Journal of Neuroscience
Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine | PLOS ONE
D-serine amino acid molecule, illustration - Stock Image - F030/5531 - Science Photo Library
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction | PNAS
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. | Semantic Scholar
Diseases | Free Full-Text | D-Amino Acids as a Biomarker in Schizophrenia
D-Serine in Neuropsychiatric Disorders: New Advances
Glutamate and Schizophrenia: From Theory to Treatment Implications
The therapeutic effects and possible underlying mechanisms of D-amino... | Download Scientific Diagram
D-Serine in Neuropsychiatric Disorders: New Advances
Pharmacotherapy of cognitive deficits in schizophrenia | CNS Spectrums | Cambridge Core
Multi-Scale Understanding of NMDA Receptor Function in Schizophrenia
Effects of D-serine on auditory plasticity. (A) Line graph of % change... | Download Scientific Diagram
Relationship between D-Amino Acids and Schizophrenia | Encyclopedia MDPI
![PDF] The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b396b28a3e1ddcd7a245f2fe22ad9b0a76503713/3-Figure1-1.png "PDF] The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia | Semantic Scholar")
PDF] The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia | Semantic Scholar
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists: Cell
Model for D-serine signaling in the brain. D-serine is synthesized from... | Download Scientific Diagram
d-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders | Translational Psychiatry
Frontiers | D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia - Ju-Chun Pei, Wei-Li Hung, Bei-Xuan Lin, Min-Han Shih, Liang-Yin Lu, Da-Zhong Luo, Hwan-Ching ...
Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion | Molecular Psychiatry
D-serine | C3H7NO3 - PubChem
Glutamate hypothesis in schizophrenia - Uno - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial - The Lancet Psychiatry
